Preeclampsia
-
A case of severe preeclampsia in a fit and healthy primigravida during 33/40
-
A Combined First-Trimester Risk Approach for Preterm Preeclampsia and Preterm Small-for-Gestational-Age: Defining a High-Risk Placental Dysfunction Population
-
A Window to Preeclampsia: Third Trimester Insights from Ophthalmic Artery Doppler
-
Angiogenic Imbalance During Pregnancy and Memory Impairment 3–6 Years Postpartum
-
Aspirin delays preeclampsia in women with chronic hypertension
-
Aspirin delays the gestational age at diagnosis of and delivery with preeclampsia: evidence from a randomized clinical trial in Asia
-
Aspirin for the prevention of preeclampsia: the role of first-trimester risk
-
Association between the sFlt-1/PlGF ratio and ophthalmic artery Doppler in near-term pregnancies: a potential surrogate for angiogenic imbalance
-
Cardiovascular Adaptation in pregnancies at High-Risk of Preeclampsia: A Longitudinal Study from Early to Late Pregnancy
-
Characterizing the Association Between Hypertriglyceridemia and the Risk of Pre-Eclampsia: Predictors and Contributing Factors
-
Clinical utility of the sFlt-1/PlGF ratio at 26 weeks for estimating the risk of preeclampsia, fetal growth restriction and placental abruption in high-risk patients
-
Comparing Acute Fatty Liver Of Pregnancy From Hellp Syndrome. New Diagnostic Approach Using Serological Markers
-
Comparison Of Glycosylated Fibronectin Point-Of-Care Test With SFLT/PLGF Ratio For Assessment Of Preeclampsia
-
Cost-benefit analysis of adding PlGF in screening for PE
-
Daytime Variations in Urinary Protein to Creatinine Ratio among Pregnant Women with and without Hypertensive Disorders
-
Decoding Preeclampsia: Exploring Placental Molecular Signatures Across Subtypes
-
Dual Prediction of Preeclampsia by Third Trimester Congo Red Test and Pro- and Anti-Angiogenic Markers and their Cost Benefit Analysis In The Israeli Healthcare System
-
Early-onset preeclampsia with and without prophylactic aspirin; is there a real difference in pregnancy outcomes?
-
EASIX (endothelial activation and stress index) for prediction of adverse maternal and perinatal outcomes in preeclampsia
-
Effect of aspirin on maternal hemodynamics in Chinese women at high-risk for preeclampsia: a longitudinal study
-
Effect of Low Molecular Weight Heparin (LMWH) in patients with Fetal Growth Restriction (FGR)
-
Effect of parity on maternal hemodynamic profile during pregnancy: a longitudinal study
-
EHealth interventions for hypertensive disorders of pregnancy and preeclampsia
-
Epidemiology and associated factors of superimposed preeclampsia in pregnant women with chronic hypertension: A retrospective multicenter cohort study
-
Evaluating PlGF Before 11 Weeks: Can Early First-Trimester Levels Predict Preeclampsia?
-
Extra Virgin Olive Oil and preeclampsia: association to blood pressure, angiogenic profile and uterine Doppler
-
Fetal Growth and Doppler after Aspirin Discontinuation
-
Fetal growth restriction and sFlt-1/PlGF ratio in severe preeclampsia
-
Fetal Medicine Foundation first trimester preeclampsia risk estimate: A window into long-term maternal cardiovascular health
-
First-trimester screening for preeclampsia in women carrying a fetus with a major congenital heart defect
-
First-Trimester sequential screening for preeclampsia using angiogenic factors: A prospective, multicenter, real-world clinical practice study (CRISP)
-
Functional differences in the placenta of pregnancies affected by preeclampsia or fetal growth restriction
-
Gestational metabolic shift signifies the effectiveness of aspirin treatment for women at risk of preeclampsia
-
High Risk of Preeclampsia: Is It Only Preeclampsia We Need to Worry About?
-
How does the FMF first-trimester risk assessment for preterm preeclampsia perform in women with maternal and obstetric high-risk factors who are eligible for aspirin prophylaxis according to current Danish guidelines?
-
Impact of aspirin and dietary salicylates on biochemical markers of preeclampsia in rats
-
Implantation on- a chip model in preeclampsia
-
Implementation of Real-Time Placental Growth Factor (PlGF) in a Tertiary Canadian Centre: Association with Ultrasound findings and Perinatal Outcomes
-
Inverting the pyramid” of specialist antenatal care: Reducing preterm preeclampsia with the IMAP (Initial Maternity Assessment and Planning) Service
-
Low Molecular Weight Heparin (LMWH) in pregnancies with Fetal Growth Restriction (FGR) and Normal Fetal Growth (NFG) with suspected placental dysfunction
-
Machine learning to Improve Prediction of Late-Onset Preeclampsia
-
Maternal and perinatal outcomes in non-severe late preterm preeclampsia managed with PlGF: real-life validation of the MAP trial
-
Midtrimester arterial stiffness among women at high-risk for preterm preeclampsia
-
Ophthalmic Artery Doppler and Carotid Intima-Media Thickness 3 to 6 Years Postpartum in Women With and Without a History of Placental Insufficiency
-
Pentraxins 3 levels in pregnant women diagnosed with preeclampsia and their relationship with the severity of the condition
-
Performance of an intensive follow-up strategy for patients with a positive first-trimester screening of preterm preeclampsia
-
Perinatal Outcomes associated with Maternal Placental Growth Factor (PlGF) collected from 12w to 20w6d
-
Peripartum Cardiomyopathy Presenting as Acute Heart Failure in a Preeclamptic Postpartum Patient: A Case Report
-
Posterior Reversible Encephalopathy Syndrome in the Immediate Postpartum Period
-
Prediction of Fetal Death in Preterm Preeclampsia Using Fetal Sex, Placental Growth Factor and Gestational Age
-
Prediction of preeclampsia: Blood pressure measured at 6-10 weeks in primary care versus 11-14 weeks at first-trimester ultrasound
-
Predictive performance of the Fetal Medicine Foundation first trimester screening for preeclampsia in pregnancies following assisted reproduction
-
Predictive value of mean platelet volume, neutrophil-to-lymphocyte ratio and platelet- to-lymphocyte ratio in the second trimester blood test for preeclampsia
-
Predictive value of mean platelet volume, neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in the first trimester blood test for preeclampsia
-
Predictors Of Blood Pressure And Hypertensive Syndromes In Brazilian Pregnant Women With Previous Diabetes Mellitus
-
Preeclampsia prediction by machine learning in twin pregnancies
-
Prophylactic Aspirin Treatment for Preeclampsia Prevention in Dichorionic-Diamniotic Twin Pregnancies
-
Refractory epistaxis in pregnancy potentially induced by the use of aspirin: Case report
-
Retroplacental hematoma in 18. weeks of pregnancy with subsequent development of severe preeclampsia and fetal growth restriction
-
Risk of Superimposed Preeclampsia and Adverse Maternal and Perinatal Outcomes in Pregnant Women with Chronic Hypertension
-
Role of Resistin in Early Prediction of Preeclampsia during the 11-13.4 weeks scan
-
Soluble fms-like tyrosine kinase-1 (sFlt-1) before 11 weeks for the prediction of preterm and early preeclampsia
-
The American College of Cardiology / American Heart Association classification of chronic hypertension in pregnancy has better clinical applicability and risk assessment than the traditional high and low risk hypertension approach – lessons from a populat
-
The effect of diabetes mellitus type 1 (T1DM) in pregnancy on the levels of biomarkers of preeclampsia: results of a single-centre prospective study
-
The impact of 1st trimester PE screening combined with 2nd trimester PTB screening: the PREVENTION-pilot study
-
The impacts of the mode of conception on preeclampsia risk prediction and pregnancy outcomes in twin pregnancies
-
The Placenta And Its Location In Determining The Clinical Picture Of Preeclampsia
-
The role of vascular endothelial growth factor (VEGF) and soluble receptor of vascular endothelial growth factor (VEGF-R) in the ethiopathogenesis of preeclampsia
-
Third trimester screening for preeclampsia in twins: comparative performance of FMF algorithm, Roche and Quidel triages
-
Ultra-processed foods consumption and risk of preeclampsia
-
Uterine artery hemodynamics and vitamin D status: a new opportunity for predicting and preventing preeclampsia?